USA - New York Stock Exchange - NYSE:IVC - US4612031017 - Common Stock
The current stock price of IVC is 0.6598 USD. In the past month the price increased by 57.1%. In the past year, price decreased by -69.17%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.76 | 223.72B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.69 | 205.85B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.22 | 149.60B | ||
| SYK | STRYKER CORP | 28.27 | 142.33B | ||
| IDXX | IDEXX LABORATORIES INC | 59.95 | 60.48B | ||
| BDX | BECTON DICKINSON AND CO | 13.45 | 55.58B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.75 | 50.34B | ||
| RMD | RESMED INC | 25.76 | 37.22B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.57 | 36.73B | ||
| DXCM | DEXCOM INC | 33.62 | 24.52B | ||
| PODD | INSULET CORP | 71.51 | 22.99B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 12.06 | 19.32B |
Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. The company is headquartered in Elyria, Ohio and currently employs 3,000 full-time employees. The firm provides clinically complex medical device solutions for congenital, acquired and degenerative conditions. Its segments include North America and Europe. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, seating and positioning products and power add-ons. Its lifestyle products include pressure relieving sleep surfaces, safe patient handling, beds, manual wheelchairs and personal care products. Its respiratory therapy products include stationary oxygen concentrators, portable oxygen concentrators and oxygen refilling devices. The company also offers repair services, equipment rentals and external contracting. The company sells its products to home medical equipment providers, through retail and e-commerce channels, residential care operators, dealers and government health services.
INVACARE CORP
P O Box 4028, One Invacare Way
Elyria OHIO 44035 US
CEO: Matthew E. Monaghan
Employees: 3000
Phone: 14403296000.0
Invacare Corp. engages in the manufacture and distribution of medical equipment used in non-acute care settings. The company is headquartered in Elyria, Ohio and currently employs 3,000 full-time employees. The firm provides clinically complex medical device solutions for congenital, acquired and degenerative conditions. Its segments include North America and Europe. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, seating and positioning products and power add-ons. Its lifestyle products include pressure relieving sleep surfaces, safe patient handling, beds, manual wheelchairs and personal care products. Its respiratory therapy products include stationary oxygen concentrators, portable oxygen concentrators and oxygen refilling devices. The company also offers repair services, equipment rentals and external contracting. The company sells its products to home medical equipment providers, through retail and e-commerce channels, residential care operators, dealers and government health services.
The current stock price of IVC is 0.6598 USD. The price decreased by -2.25% in the last trading session.
IVC does not pay a dividend.
IVC has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
INVACARE CORP (IVC) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
INVACARE CORP (IVC) has a market capitalization of 24.91M USD. This makes IVC a Nano Cap stock.
ChartMill assigns a technical rating of 4 / 10 to IVC. When comparing the yearly performance of all stocks, IVC is a bad performer in the overall market: 91.81% of all stocks are doing better.
ChartMill assigns a fundamental rating of 2 / 10 to IVC. Both the profitability and financial health of IVC have multiple concerns.
Over the last trailing twelve months IVC reported a non-GAAP Earnings per Share(EPS) of -2.04. The EPS decreased by -137.21% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 4.82 |
6 analysts have analysed IVC and the average price target is 1.68 USD. This implies a price increase of 155.08% is expected in the next year compared to the current price of 0.6598.
For the next year, analysts expect an EPS growth of -309.94% and a revenue growth -16.76% for IVC